Pregabalin Completed Phase 3 Trials for Seizure Disorder, Partial Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00141245To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00141336To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00141388To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures
NCT00150293Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.